Shin et al, Cell Rep. 2024
Read MoreStart typing to search for blog entry:
A viral vaccine design harnessing prior BCG immunization confers protection against Ebola virus→
/
Ng et al, Front Immunol. 2024
Read More
Design and characterization of protective pan-ebolavirus and pan-filovirus bispecific antibodies→
/
Wirchnianski et al, PLoS Pathog. 2024
Read MoreCase of Human Orthohantavirus Infection, Michigan, USA, 2021→
/
Goodfellow et al, Emerg Infect Dis. 2024
Read MoreBroad antibody and T cell responses to Ebola, Sudan, and Bundibugyo ebolaviruses using mono- multivalent adjuvanted glycoprotein vaccines→
/
Felgner et al, Antiviral Res. 2024
Read More
Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge→
/
Hsieh C-L et al, Nat Commun 2024
Read MoreTwo point mutations in protocadherin-1 disrupt hantavirus recognition and afford protection against lethal infection→
/
Slough MM et al, Nat Commun 2023
Read MoreStructural and mechanistic basis of neutralization by a pan-hantavirus protective antibody→
/
Mittler E et al, Science Transl Med 2023
Read MoreA Pan-ebolavirus Monoclonal Antibody Cocktail Provides Protection against Ebola and Sudan Viruses→
/
Liu G et al, J Infect Dis 2023
Read MoreTNF-α Limits Serological Memory by Disrupting the Bone Marrow Niche→
/
Aaron T et al, J Immunol 2023
Read MoreCell-impermeable staurosporine analog targets extracellular kinases to inhibit HSV and SARS-CoV-2→
/
Cheshenko N et al, Commun Biol 2022
Read MoreGenomic surveillance of SARS-CoV-2 during the first year of the pandemic in the Bronx enabled clinical and epidemiological inference→
/
Fels JM et al, Cold Spring Harb Mol Case Stud 2022
Read MoreA Powassan virus domain III nanoparticle immunogen elicits neutralizing and protective antibodies in mice→
/
Malonis RJ et al, PLoS Pathog 2022
Read MoreInduction of SARS-CoV-2 neutralizing antibodies by CoronaVac and BNT162b2 vaccines in naïve and previously infected individuals→
/
Muena N et al, EBiomedicine 2022
Read MoreHuman antibody recognizing a quaternary epitope in the Puumala virus glycoprotein provides broad protection against orthohantaviruses→
/
Mittler E et al, Science Transl Med 2022
Read MoreGenotype-specific features reduce the susceptibility of South American yellow fever virus strains to vaccine-induced antibodies→
/
Haslwanter D et al, Cell Host Microbe 2022
Read MoreEfficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients: A Randomized Clinical Trial→
/
Ortigoza MB et al, JAMA Internal Med 2022
Read More